Copy number variants at chromosome 17q12 have been associated with a spectrum of phenotypes.
| Psychiatric and psychometric assessment
We conducted a detailed psychiatric assessment, including developmental history, substance use history and mental state examination.
We supported formal psychiatric diagnoses with appropriate diagnostic instruments. We used the psychiatric assessment schedules for adults with developmental disabilities (PAS-ADD) (Moss et al., 1997 ) a diagnostic instrument for mental disorders that is also suitable for people with learning difficulties and the Structured Clinical Interview for personality disorders (First et al., 1997) . We used the diagnostic information obtained through the psychiatric interview and the PAS-ADD to formulate diagnoses according to the criteria of the DSM5. We also conducted the structured interview for prodromal syndromes to explore the presence of subclinical or prodromal psychotic symptoms (Miller et al., 2003) . We assessed the severity of current psychotic symptoms in maternal uncle (II: 4) with the scale for the assessment of positive symptoms and scale for the assessment of negative symptoms (SAPS and SANS) (Andreasen, 1990) intelligence quotient (IQ) was assessed using the Wechsler Abbreviated Scale of Intelligence, which yields a full-scale IQ and separate scores for the verbal and performance domains (Wechsler, 2011) .
| RE S U L TS

| Genotyping
We identified a 1.8 Mb interstitial duplication of the long arm of chromosome 17 at q12 (chr17: 34, 468, 248, 888 
| Clinical reports
Proband (III: 3 see Figure 1 ) (Figure 2a,b) : The index case is a 20-yearold man who is the third child of a nonconsanguineous couple and was first seen in the genetics clinic at the age of 7 years. His prenatal period was complicated as his mother developed protein losing nephropathy with subsequent pre-eclampsia. He was born at 36 weeks gestation with a birth weight between 50 and 75th centile. He was reported to be a content baby but did not breast feed and suffered with constipation. He was noted to have global DD in the first few months of life.
He sat at the age of 12 months and walked at the age of 19 months.
He had difficulties manipulating small objects, could not skip until 10, only learned to tie his shoelaces at 13 and to ride a two-wheeled bike at 20 years of age. His speech was also significantly delayed with the first meaningful word noted at the age of 2 years, and he displayed prominent echolalia. He had difficulties with his coordination whilst growing up and received additional support from a home-visiting educational service for children with additional support needs ("portage help"). He attended a special school and did a life skills course in college. He currently attends day centers 5 days a week. He lives with his mother and stepfather and has some skills of independent living but needs regular prompting for everyday activities. His mother prepares all his meals and organizes all his appointments and activities.
A diagnosis of attention deficit hyperactivity disorder (ADHD) with autistic tendencies was suggested by the mental health team at the age half-brother of the proband's mother has a history of DD and had experienced behavioral problems since childhood. There were no antenatal problems. He had feeding difficulties in infancy, severe constipation and speech delay, hyperactivity, and a poor attention span. His motor development was normal. He had sleeping problems and motor stereotypes (rocking). He had one seizure aged seven and was on antiepileptic medication for a few years. He attended a special school for pupils with additional learning needs. He had an operation for testicular torsion aged 12, and an appendectomy aged 15. He had been assessed for specific language impairment, autistic traits, and possible psychotic traits. He also has DM type 2, HTN, angina, and irritable bowel syndrome. He is being followed-up for chronic renal impairment, probably secondary to his poorly controlled diabetes. Renal ultrasound scan revealed no abnormality. As reported by his mother, he frequently stops breathing during his sleep; he feels tired during the day and frequently falls asleep and chokes. He has recently been prescribed a CPAP device. 
| Summary of clinical phenotype
Three out of five family members have been diagnosed with DM type 2, two suffered from recurrent tonsillitis requiring a tonsillectomy, one female had gallstones and a cholecystectomy (Table 1) . Three family members have a history of seizures. One female has polycystic ovaries.
Only one female had a primary renal problem needing a renal transplantation whereas the other four members had normal renal scans.
The index case has ASD and ID, his maternal uncle suffers from schizophrenia and one of his sisters has attenuated positive symptoms of psychosis. Three family members have suffered from episodes of severe to moderate depression. The index case's sister currently fulfills diagnostic criteria for a major depressive episode; she also suffers from agoraphobia, GAD, social anxiety disorder, and avoidant personality disorder.
All female members of the family seem to be sensitive to hormonal changes with PMDD, severe postpartum depression (in two family members) and perimenopausal mood changes (in one family member).
| D I SCUSSION
This three-generation family, as well as previously published cases, provides further evidence for pathogenicity of the17q12 duplication. Main features include ID, psychosis, autistic spectrum disorder, epilepsy, diabetes, renal disorder, and mild dysmorphic features. However, there is significant phenotypic variability, and the duplications are commonly found in apparently unaffected parents.
Determining the significance of novel CNVs is challenging. Statistically a deletion or duplication is deemed pathogenic if it is clearly enriched in affected individuals compared with unaffected individuals (Mefford, 2009) . The occurrence of a de novo CNV in a symptomatic patient is more than likely to be pathogenic; however, deletions and duplications can no longer be dismissed because they are inherited from an apparently unaffected parent (Mencarelli et al., 2008) . Duplication of 17q12 represents a rare CNV in the normal population and is slightly enriched in patients with ID, epilepsy and schizophrenia (Mefford et al., 2007; Szatkiewicz et al., 2014) . Factors such as incomplete penetrance, genetic modifiers, epigenetic/environmental factors, and difference in size of the deletion/duplication may account for the phenotypic variability of the rearrangement (Mefford et al., 2007; Mencarelli et al., 2008) .
Interrogating the DECIPHER database (Firth et al., 2009 ); we identified more than 100 patients with similar duplications of varying sizes, overlapping with or mapping within the duplication detected in our family at 17q12. Reviewing the 64 patients for whom phenotypic features were available, the majority of the patients were reported as having ID and dysmorphic features. Autism/behavioral problems and seizures were seen in 15 and 5 patients respectively; psychosis was reported in one patient. Multiple renal cysts were documented in three patients and obesity in two patients. Brain anomalies (cerebellar hemisphere hypoplasia, agenesis of corpus callosum, abnormal central nervous system myelination), eye problems, microcephaly, hypotonia and short stature were some of the other features documented. Out of the 99 cases, the inheritance was unknown in 53 cases (53.5%) and in the remaining 46 cases, the duplication was inherited from a parent in 39 of them, majority of the parents were reported as having no health problems.
The comparison of the cases of 17q12 duplication reported in the literature and our family (Table 2) Esophageal fistula, Radial defects, and Renal anomalies. The underlying molecular mechanism of esophageal atresia and VATER association is not known. Smigiel et al. (2014) proposed the role of selected genes such as AATF and TADA2L at the 17q12 region in the development of esophageal atresia.
The 17q12 duplication has been reported previously to be associated with autism and repetitive behaviors (Bierhals et al., 2013; Brandt et al., 2012) . Psychotic symptoms have also been described with 17q12 duplication (Nagamani et al., 2010) . A Genome wide survey by Szatkiewicz et al. (2014) for CNVs associated with schizophrenia showed an association of 17q12 duplications with schizophrenia. These findings, in addition to the first report of a patient with 17q12 duplication and treatment-resistant schizophrenia described by Rogdaki et al (2016) , confirm the association between 17q12 duplication and schizophrenia.
Deletions in chromosome 17q12, including the HNF1b gene, are associated with cystic renal disease and maturity onset diabetes of the young (Mefford et al., 2007) . A subset of patients with 17q12 duplication reported in the literature as well as one member in our family had renal disease. Deletion and duplication rearrangements may convey phenotypes by various molecular mechanisms, including altering the copy number of dosage-sensitive genes, interrupting genes, gene fusion, functional polymorphism, and other mechanisms (Lupski & Stankiewicz, 2005) . This therefore, raises the possibility, whether renal problems and a propensity to DM type 2 are a part of the 17q12 duplication syndrome.
Overexpression of the genes in the 17q12 region could explain the associated phenotype, and some potential genes have been proposed as candidates for specific phenotypes associated with this rearrangement. Five genes are known to be of some importance in human disease: CCL3L1 (susceptibility to HIV/AIDS), ACACA (Acetyl-CoenzymeA Carboxylase Alpha), and HNF1B (Noninsulin dependent Diabetes Mellitus, renal cysts and diabetes, renal cell carcinoma), PIGW (hyperphosphatasia with mental retardation syndrome 5) and ZNHIT3 (PEHO syndrome). The LHX1 gene also maps to this region and is expressed in the human brain, thymus, and tonsillar tissue. It encodes a transcriptional regulatory protein involved in the control of differentiation and development of neural and lymphoid cells (Dong et al., 1997) . Mouse mutants that lack LHX1 function had a severely compromised head formation (Shawlot & Behringer, 1995) . It is hypothesized that the LHX1 gene is dosage-sensitive and may be responsible for some of the neurocognitive (Nagamani et al., 2010) and urogenital phenotypes associated with 17q12 rearrangements. The duplication of the ACACA gene in the 17q12 region has also been implicated in the generation of neurodevelopmental symptoms, including seizures (Hardies et al., 2013 ).
This gene is involved in acetyl-CoA metabolism and its duplication would lead to overutilization of acetyl-CoA which could result in a global energy failure of the brain. However, a causal role has not been validated for any of these genes, and further studies are needed to elucidate candidate genes associated with specific clinical features of the 17q12 locus. Also, the possibility of a contiguous gene syndrome should be considered. 
